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CHAPTER I 
   INTRODUCTION 
 
1.1 Significance of research 
 Cholangiocarcinoma (CCA) is a fatal cancer that develops along the biliary 
tract.  CCA is a rare tumor world-wide and high incidence rate of this malignancy is 
found in Southeast Asia, and particularly in the Northeast Thailand.  This is due to 
strong association between CCA and chronic inflammation by food-borne liver fluke 
Opisthorchis viverrini (Ov) that is classified to be group 1 carcinogen by WHO’s 
International Agency for Research on Cancer.  CCA is a highly metastasis with poor 
prognosis and responds poorly to current chemo- and radiotherapy.  Surgical resection 
is the treatment of choice for early stage of the disease but most patients are 
diagnosed at advance stage and some is inoperable.  Thus surgical resection is 
considered as palliative treatment for the CCA patients. 
Genetic mutations are associated with the formation and progression of cancer, 
and it also has significant clinical implications from diagnosis to therapy.  Recently, 
the active mutation in well-known cancer genes (TP53, Kras and SMAD4) and novel 
mutated genes (MLL3, RNF43, GNAS and PEG3) have been documented in patients 
with Ov-related CCA using whole exome sequencing technique.  Alteration of these 
mutated genes involves in seven biological processes or pathways; genome stability, 
transforming growth factor beta (TGF-b)/SMAD4 signaling, KRAS and G protein 
signaling, epigenetic regulation, WNT signaling, cell cycle control and AKT and
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PI3K signaling.  Of particular concerning among biological pathway is Wnt signaling 
which has several newly mutated genes (RNF43 and PEG3) involved and that have 
never been demonstrated the role in cholangiocarcinogenesis.  RNF43 or Ring finger 
protein 43 is an E3 ubiquitin-protein ligase that proposed to inhibit Wnt signaling by 
1) interacting with the Wnt receptors of the frizzled, and 2) sequestering TCF4 to the 
nuclear membrane.  RNF43 is frequently mutated in several types of cancers, 
including CCA.  It has been demonstrated in approximately 3-10% of both Ov and 
non Ov-related CCA.  In addition, poorer survival was observed in CCA patients with 
inactive RNF43 mutations.  However, the significance of RNF43 in CCA; expression 
level and its role in Wnt signaling has not been reported in CCA.  
In present study, we investigated the 1) RNF43 protein and mRNA expression 
and the correlation with RNF43 somatic mutation status, and clinicopathological 
features and 2) the biological roles of RNF43 in CCA.  The finding obtained from the 
current study may provide the crucial roles of RNF43 in Wnt signaling during 
development and progression of CCA and the RNF43 expression may have a potential 
for diagnostic and monitoring CCA patients.  
 
 
1.2 Literature reviews 
 1.2.1 Significance of cholangiocarcinoma (CCA) 
  Cholangiocarcinoma (CCA) is bile duct cancer that arises from the 
ductular epithelium of the biliary tree, either within the liver or more commonly from 
the extrahepatic bile ducts (Olnes and Erlich, 2004).  CCA can be classified 
anatomically into intrahepatic or extrahepatic tumors.  In the case of intrahepatic 
tumors is further classified by growth characteristics or macroscopic into mass-
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forming, periductal infiltrating or intraductal growth type (Bhudhisawasdi et al., 2012; 
Khan et al., 2005) (Figure 1.1).  Mass-forming type arises from peripheral intrahepatic 
small bile duct that manifests as a large, white tumor with dense fibrosis and high 
metastasis.  Periductal infiltrating type is the most common type of CCA in the hilar 
area and demonstrates very small fibrotic tumors which cause segmental dilatation of 
the bile ducts.  Intraductal growth type is the least common but it  has a better 
prognosis than other types and is characterized by intraductal growth with little or no 
extension beyond the bile duct walls (Han et al., 2002).  Histologically, CCA is 
classified further according to grade as being well, moderately, or poor differentiated, 
with the classic diagnosis being well-to moderately-differentiated ductal 
adenocarcinoma.  CCA is a devastating malignancy that presents late, is notoriously 
difficult to diagnose, and is associated with a high mortality.  Surgical treatment is the 
only treatment of choice for this tumor because of its late clinical presentation and the 
lack of effective non-surgical therapeutic modalities (Leyva-Illades et al., 2012).   
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Figure 1.1 Intrahepatic cholangiocarcinoma is classified into mass-forming (A1, B1), 
periductal infiltrating (A2, B2) and intraductal growth (A3, B3) (Bhudhisawasdi et al., 
2012). 
 
 1.2.1.1 Epidemiology and Etiology of CCA 
  CCA is a rare tumor world-wide but high incidence rates have been 
reported in Southeast Asia, especially in Northeast Thailand (Parkin et al., 1993).  
CCA is the second-most common primary liver cancer and accounts for an estimated 
15% of primary liver cancer worldwide; however, its prevalence varies widely by 
region, from 5% in Japan (Primary liver cancer in Japan 1990) to 20% in Pusan 
(Busan), Korea (Jung et al., 1993) and up to 90% in Khon Kaen, Thailand (Parkin et 
al., 1993). 
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 The etiology of CCA are still unknown, although chronic inflammation 
and cellular injury within bile ducts, together with partial obstruction of bile duct flow 
(Gores, 2003; Sirica et al., 2002) manifest as high risk conditions for CCA 
development.  Well established risk factors in Western country include primary 
sclerosing cholangitis, hepatolithiasis, and choledochal cysts, whereas less-established 
potential risk factors include inflammatory bowel disease, hepatitis C virus, hepatitis 
B virus, cirrhosis, diabetes, obesity, alcohol consumption and smoking (Rizvi and 
Gores, 2013).  In Eastern countries, liver fluke, Opisthorchis viverrini (Ov) infection 
is the major risk factor of CCA in Thai, Lao, and Malaysian cases, while Clonorchis 
sinesis infection is prominent in Japanese, Korean, and Vietnamese cases 
(Kullavanijaya et al., 1999; Sithithaworn et al., 1994).  In addition, these two liver 
flukes are listed as a human carcinogen in 1994 and 2007, respectively by 
International Agency for Research on Cancer (IARC) (IARC, 1994;2012). 
  1.2.1.2 Pathogenesis of Ov- associated CCA 
  Pathological consequences of Ov infection occur mainly in the bile 
duct within liver, extrahepatic bile ducts and gallbladder, and have been described in 
both humans and animal models.  The severity of the pathology appears to be 
associated with both intensity and duration of infection (Sripa, 2003).  The main 
histopathologic features of Ov both in man and animal model are inflammation, 
epithelial desquamation, epithelial and adenomatous hyperplasia, goblet cell 
metaplasia, periductal fibrosis, and granuloma formation (Figure 1.2). 
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Figure 1.2 Histopathology of Ov- infected human liver showing periportal 
inflammation, adenomatous hyperplasia and periductal fibrosis (Sripa and Pairojkul, 
2008).  The adult parasite is seen in the bile duct lumen (black arrow). 
 
 Ov- induced CCA is a result of chronic inflammation.  Several mechanisms 
by which Ov infection may enhance cholangiocarcinogenesis have been proposed 
(Figure 1.3).  Biliary epithelial desquamation may be due to mechanical irritation 
caused by the liver fluke and/or its metabolic products; however, immunopathological 
processes may contribute to the long standing hepatobiliary damage.  With liver fluke 
infection, inflammation, periductal fibrosis and proliferative responses, including 
epithelial hyperplasia, goblet cell metaplasia and adenomatous hyperplasia, may 
represent predisposing lesions that enhance susceptibility of DNA to carcinogens.  
Several nitric oxide compounds and their precursors occur at low levels in fermented 
food, such as preserved mud fish paste, pla-ra, that is a common food additive in 
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Northeast Thailand.  In addition, endogenous nitric oxide caused by Ov infection and 
inflammation has been observed in animals and humans.  Both exogenous and in-situ 
nitrosamine formation may lead to DNA alkylation and deamination in predisposed 
and inflamed tissues (Sripa et al., 2007).  Moreover, excess nitric oxide and other 
reactive oxygen intermediates produced by inflammatory cells during infection might 
exert direct cytotoxic and mutagenic effects and increase cell proliferation.  It has 
been reported the excess of nitric oxide- mediated DNA damage in biliary epithelium 
of hamsters infected with Ov (Kawanishi et al., 2006; Pinlaor, Hiraku, et al., 2004), 
and repeated infections with the liver fluke result in enhanced biliary DNA damage 
(Pinlaor, Ma, et al., 2004).  Additionally, due to lower rates of apoptosis of the 
infected biliary epithelium, after several successions of replication, genetic alterations 
may become fixed, which can lead to malignant transformation (Sripa et al., 2007). 
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Figure 1.3 Proposed mechanisms of Ov- induced CCA.  The liver fluke induces 
damage to the bile duct tissue at least by two pathways: mechanical (by parasite 
sucker/excretory-secretory products) and immune pathology to parasite antigens.  
Inflammation-induced oxidative DNA damage occurs concurrent with biliary 
epithelial proliferation driven by parasite molecules.  Damaged DNA/genes after 
successive replication become fixed and lead to malignant transformation.  NO, nitric 
oxide; ROI, reactive oxygen intermediates (Sripa and Pairojkul, 2008). 
 
 1.2.1.3 Mutational landscape of Ov-associated CCA 
  Chronic Ov infection and inflammation are proposed to contribute 
genetic alteration in Ov-related CCA (Sripa and Pairojkul, 2008).  In recent years, 
high-throughput next-generation sequencing has enabled comprehensive mutational 
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profiling of Ov-associated CCA.  The CCA-related mutant genes, including TP53 
(44%), KRAS (16.7%) and SMAD4 (16.7%) are identified using exome-capturing 
resequencing.  Besides known mutations, several novel mutated genes are found, 
including inactivating mutations in MLL3 (in 14.8% of cases), ROBO2 (9.3%), 
RNF43 (9.3%) and PEG3 (5.6%), and activating mutations in the GNAS oncogene 
(9.3%) (Table 1.1) (Ong et al., 2012).  While non-Ov related CCA reported the 
recurrent somatic mutations in BAP1 and ARID1A (Chan-On et al., 2013).  
Comparisons between Ov and non–Ov–related CCAs demonstrate statistically 
significant differences in mutation patterns: BAP1, IDH1 and IDH2 are more 
frequently mutated in non– Ov related CCAs, whereas TP53 mutations show the 
reciprocal pattern (Chan-On et al., 2013) (Table 1.1).  Furthermore, the commonly 
mutated genes in Ov-related CCA can be functionally grouped into seven biological 
pathways, including genome stability, transforming growth factor beta (TGF-
β)/SMAD4 signaling, KRAS and G protein signaling, epigenetic regulation, Wnt 
signaling, cell cycle control, and AKT/PI3K signaling (Jusakul et al., 2015) (Figure 
1.4).  TP53 is involved in genomic stability and it has been reported the TP53 
mutations in mice cause the progression of epithelial hyperplasia of bile duct to 
malignant intrahepatic CCA (Farazi et al., 2006).  KRAS is involved in RAS/RAF 
pathway alteration.  In addition, both TP53 and KRAS mutations have been shown to 
play an important role in CCA tumorigenesis.  While newly mutated genes are 
involved in the Wnt signaling pathway, RNF43 and PEG3 are negative regulators of 
Wnt with role in regulating genomic stability though p53 regulation.  In contrast, the 
chromatin modifiers including BAP1, ARID1A, PBRM1 and IDH are highly mutated 
in non-Ov related CCA.  These indicate that histone dysregulation is a major 
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biological pathway which is involved in carcinogenesis of non-Ov related CCA.  
Taken together, this information indicates that different causative etiologies may 
induce distinct somatic alterations, even within the same tumor type (Chan-On et al., 
2013). 
 Based on the information of genomic alteration in CCA, RNF43 is a novel 
mutated gene, which is detected in both Ov and non-Ov related CCA.  It has also 
shown that the presence of RNF43 somatic mutations associates with poor patient 
survival.  These data motivate us to study the RNF43 expression and its role in Ov-
related CCA. 
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Table 1.1 Commonly mutated genes in Ov-related and non-Ov-related CCA (Jusakul 
et al., 2015). 
Genes 
Ov-related CCA (%)  Non-Ov-related CCA (%) 
Thailand 
(n=54)
a
 
Thailand 
(n=108)
b
 
 
Singapore + 
Romania 
(n=86)
b
 
Europe 
(n=32)
c
 
TP53 44.4 39.8  9.3 6 
KRAS 16.7 13.9  11.6 3 
SMAD4 16.7 19.4  5.8 0 
CDKN2A 5.6 NR  NR 3 
MLL3 14.8 13.0  3.5 NR 
ROBO2 9.3 5.6  2.3 NR 
GNAS 9.3 5.6  0 NR 
RNF43 9.3 7.4  3.5 NR 
PTEN 3.7 NR  0 6 
BAP1 NR 2.8  10.5 25 
ARID1A NR 17.6  10.5 19 
IDH1/2 NR 2.8  9.3 19 
PBRM1 NR NR  NR 17 
a
(Ong et al., 2012); 
b
(Chan-On et al., 2013); 
c
(Jiao et al., 2013)  
CCA, cholangiocarcinoma; NR, not reported. 
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Figure 1.4 Somatic mutations and mutated pathways in Ov-related and non-Ov-
related CCA.  Left column indicates genes validated in Ong et al., 2012 and Chan-On 
et al., 2013.  Top row indicates Ov-related status. Samples with or without mutations 
are labeled in black or white, respectively. (Jusakul et al., 2015) 
 
 1.2.2 Ring finger protein 43 (RNF43) 
  RNF43 gene consists of 10 exons located within 63 kb of DNA on 
human chromosome 17q22, and encodes a single polypeptide chain of 783 amino 
acids and the molecular weight 85 kDa with an isoelectric point of about 8.10.  The 
protein encoded by this gene is a RING-type E3 ubiquitin ligase and is predicted to 
contain a signal peptide, a transmembrane domain, a protease-associated domain, an 
ectodomain, and a cytoplasmic RING domain (Figure 1.5).  RNF43 is proposed as an 
E3 ubiquitin-protein ligase that accepts ubiquitin from an E2 ubiquitin-conjugating 
enzyme and directly transfers the ubiquitin to targeted substrate proteins for protein 
degradation (Figure 1.6). 
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Figure 1.5 Schematic overview of RNF43.  The green line denotes the signal peptide.  
PA, protease-associated domain; TM, transmembrane domain; RING, RING domain. 
 
 
 
Figure 1.6 Overview of the ubiquitin - proteasome pathway. Ubiquitination, also 
known as ubiquitylation, regulates degradation of cellular proteins by the ubiquitin 
proteasome system, controlling a protein’s half-life and expression levels.  Briefly, 
Ubiquitin (Ub) is a small 8-kDa protein, which is first transferred to the ubiquitin-
activating enzyme, E1, in an ATP-dependent manner.  This activated ubiquitin is then 
transferred to the ubiquitin-conjugating enzyme, E2.  Finally, the ubiquitin is 
covalently attached to the target protein by E3 ubiquitin ligase, leading to the 
formation of a polyubiquitin chain.  The polyubiquitylated protein is recognized by 
the 26S proteasome, and is destroyed in an ATP-dependent manner (Carrier et al., 
2010). 
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  1.2.2.1 The role of RNF43 in Wnt signaling pathway 
 Wnt signaling pathway is a powerful signaling that plays a crucial role 
in cell fate determination, survival, proliferation and movement in variety of tissues 
(Moon et al., 2002).  To trigger a cellular response and activate intracellular signal 
transduction, Wnt ligands are secreted lipoglycoprotein ligands that bind to receptors 
of frizzled (FZD) family and several co-receptors including low-density lipoprotein-
related protein 5 or 6 (LRP5/6) (Klaus and Birchmeier, 2008).  Then, it results in the 
disassembly of the destruction complex consisting of axin, adenomatous polyposis 
coli (APC), and GSK3β and stabilization of β-catenin in the cytoplasm.  Cytoplasmic 
β-catenin accumulates and is eventually translocate into nuclear where it interacts 
with TCF/LEF family transcription factors and various co-factors to induce the 
expression of various selected genes including CCND1 (Cyclin D1) (Shtutman et al., 
1999), C-myc and CD44 (Sansom et al., 2004), MMP-7 (Crawford et al., 1999), 
EphB/ephrin-B (Batlle et al., 2002), ZNRF3 and RNF43 (Hao et al., 2012). (Figure 
1.7) 
RING finger protein 43 (RNF43) is an E3 ubiquitin ligase originally found in 
stem cells (LGR5 positive cells) and proposed to play a role in negative feedback 
regulation of Wnt signaling by ubiquitinating frizzled receptors at the plasma 
membrane and, consequently promote its endocytosis and lysosome degradation (Koo 
et al., 2012).  It has been demonstrated that abnormalities of this E3 ubiquitin ligase in 
particular Wnt signaling pathway are involved in various diseases including cancers.  
For example, the deletion of ZNRF3/RNF43 increases Wnt stimulation through β-
catenin/TCF activity (Jiang et al., 2015) and this activation leads to induce rapidly 
growing adenomas in animal model (Koo et al., 2012).  In addition, Wnt signals can 
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also be boosted in the presence of R-spondin (R-spo) and their receptor leucine-rich 
repeat containing G-protein coupled receptor 4 (LGR4) through direct inhibition of 
two membrane-bound E3 ligases (RNF43 and ZNRF3) (Carmon et al., 2014; Hao et 
al., 2012) (Figure 1.8).  Furthermore, the role of RNF43-mediated inhibition of Wnt 
signaling pathway is not limited at plasma membrane by selectively ubiquitinating 
frizzles receptors.  Loregger et al. have demonstrated that RNF43 is also localized at 
the nuclear envelope of human intestinal crypt and colon cancer cells.  It can 
physically interact with T cell factor 4 (TCF4) and lead to translocation of TCF4 to 
the nuclear membrane, resulting in inhibition of TCF4 transcriptional activity 
(Loregger et al., 2015). 
In summary of the data so far provide an explanation for the role of RNF43 in 
regulating Wnt signals in normal condition by 1) interacting with the Wnt receptors of 
the frizzled, and 2) sequestering TCF4 to the nuclear membrane.   
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Figure 1.7 A canonical Wnt signaling pathway. Left: In the absence of Wnt ligand, 
action of the destruction complex (CKIα, GSK3β, APC, Axin) creates a 
hyperphosphorylated β-catenin, which is a target for ubiquitination and degradation 
by the proteasome.  Right: Presence of Wnt ligand, binding of Wnt ligand to a 
frizzled/LRP-5/6 receptor complex leads to stabilization of hypophosphorylated β-
catenin, which interacts with TCF/LEF proteins in the nucleus to activate transcription 
(Eisenmann, 2005). 
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Figure 1.8 Model for R-spondin (R-spo), LGR4/5, and ZNRF3/RNF43 interactions in 
the modulation of Wnt/β-catenin signaling.  Left: In the presence of Wnt ligand and 
the absence of R-spo, the transmembrane E3 ubiquitin ligase proteins ZNRF3 or 
RNF43 (TM-RING) ubiquitinate frizzled–LRP5/6 co-receptor proteins, resulting in 
internalization and lysosomal degradation of the TM-RING–frizzled–LRP complex.  
Right: In the presence R-spo, R-spo simultaneously binds to the extracellular domains 
of ZNRF3/RNF43 and LGR4/5, and induces auto-ubiquitination in an E3 ligase-
dependent manner and membrane clearance of ZNRF3/RNF43, resulting in increased 
level of frizzled-LRP5/6 receptors at the cell surface (Fearon and Spence, 2012). 
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 1.2.2.2 The role of RNF43 in cancers 
   Oncogenic transformation is characterized by dysregulated cell growth 
signals that lead to limitless autonomous proliferation, insensitivity to anti-growth or 
pro-apoptotic signals, dysregulation of the cell cycle and genomic instability 
(Hanahan and Weinberg, 2011).  RING finger E3 ligases are implicated in all of these 
steps.  It has been reported that some are bona fide oncogenes, whereas others are 
products of tumor suppressor genes (TSGs) (Table 1.2).  For example, the RING 
finger E3 function in TSG, the anaphase-promoting complex/cyclosome (APC/C) 
consists of at least 13 subunits which have multisubunit E3s that regulate the cell 
cycle.  The frameshift and point mutations of APC/C in colon cancer cell lines and 
tumors can cause the inappropriate progression of the cell cycle, genomic instability 
and aberrant chromosome segregation (Wang et al., 2003).  In contrast, the mouse 
double minute 2 homolog (MDM2) is an oncoprotein and E3 activity which bind 
directly to P53 (TSG) means of inactivating P53 and escaping growth control in 
cancer (Marine and Lozano, 2010). 
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Table 1.2 RING finger E3s as oncogenes and tumor suppressor genes (Lipkowitz and 
Weissman, 2011). 
E3 function Role in cancer 
 A tumor suppressor gene An oncogene 
Cell Cycle APC/C ligases β-TrCP (FBW1A) 
  COP1 (RFWD2) EMI1 (FBXO5) 
  FBXW7 SKP2 
   
Genomic integrity BARD1 CUL7 
  BRCA1 MDM2 
  FANC core complex MDMX (MDM4) 
    PARC (CUL9) 
    PIRH2 (RCHY) 
   
Signal transduction TRC8 (RNF139) CBLs 
    FBXW5 
    Hakai (CBLL1) 
   
Hypoxia VHL SIAHs 
   
Metastasis   gp78 (AMFR) 
   
β-TrCP, β‑transducin repeat containing protein; AMFR, autocrine motility factor receptor; APC/C, 
anaphase-promoting complex/cyclosome; BARD1,BRCA1-associated RING domain 1; COP1, 
constitutive photomorphogenesis protein 1 homologue; CUL, cullin; EMI1, early mitotic inhibitor 1; 
FANC, Fanconi anaemia; FBXW, F‑box/WD-repeat containing protein; RFWD2, RING finger and 
WD repeat domain protein 2; RNF139, RING finger protein 139; SKP2, S‑phase kinase-associated 
protein 2; VHL, von Hippel–Lindau tumor suppressor. 
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RNF43 is a newly implicated RING finger E3 ligase in cancer.  It is frequently 
mutated in several types of malignancy, including CCA (Table 1.3).  However, the 
loss or gain-of-function mutation in RNF43 is still unclear since it can act as either an 
oncogene or a tumor suppressor gene depending on the tumor type.  In CCA, RNF43 
was thought to act as a tumor suppressor gene because CCA patients with inactive 
RNF43 mutations are associated with poorer survival (Ong et al., 2012).  Similar 
finding has demonstrated in glioma and gastric cancer where reduced RNF43 
expression is associated with poor prognosis (Niu et al., 2015; Xi et al., 2015).  In 
contrast, overexpression of RNF43 in hepatocellular (Table 1.4) reveals oncogenic 
function because the high expression of RNF43 mediates cancer cell proliferation and 
is associated with positive vascular invasion and advanced tumor stage (Xing et al., 
2013).  However, the significance of its expression and clinical correlation in CCA 
has not been reported.  
 The significant role of RNF43 in regulating Wnt signaling pathway have been 
documented in stem cells by targeting frizzled receptor for protein degradation (Koo 
et al., 2012).  This evidence was also demonstrated in pancreatic ductal 
adenocarcinoma that inactivating mutations of RNF43 confer Wnt dependency by 
increasing membrane expression of frizzled (Jiang et al., 2013).  It has been also 
demonstrated that RNF43 can interact with NEDL1 (Novel ubiquitin-protein 
isopeptide ligase for Dishevelled-1) and suppresses p53-mediate transcriptional 
activity in colorectal cancer (Shinada et al., 2011).  Similar findings have 
demonstrated in hepatocellular carcinoma that suppression of RNF43 induces the 
accumulation of G1-S phase cell cycle arrest leading to cell apoptosis via p53 
dependent pathway and inhibits cell migration and invasion (Xing et al., 2013).  In 
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contrast, suppression of RNF43 significantly promotes cell proliferation in gastric 
cancer (Niu et al., 2015) and epithelial-to-mesenchymal transition change and 
metastasis in colorectal cancer (Wang et al., 2016).  However, its role in CCA remains 
unknown.   
Taken together, RNF43 is implicated in all steps of tumor development and 
progression.  The loss or gain-of-function in RNF43 can act as either an oncogene or a 
tumor suppressor gene depending on the tumor type. 
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Table 1.3 RNF43 is frequently mutated in cancers. 
 
 
Cancers 
 
 
Percentage of 
RNF43 mutations 
 
Number of mutations 
 
 
 
References 
Missense 
 
Nonsense, 
Splice sites, 
Frameshift 
Synonymous 
 
 
Intraductal papillary mucinous 
neoplasms of pancreas ;IPMN (Japan) 
 
14 % (8/57) 
 
2 
 
6 
 
- 
 
(Sakamoto et al., 2015) 
Pancreatic cancer including IPMN 
(USA) 
31.2 % (10/32) 2 8 - (Wu et al., 2011) 
Endometrial cancer 22 % (49/222) 9 39 1 (Giannakis et al., 2014) 
Mucinous ovarian carcinomas 21 % (6/29) - 6 - (Ryland et al., 2013) 
Colorectal cancer 18.9 % (35/185) 7 26 2 (Giannakis et al., 2014) 
Cholangiocarcinoma  9.3 % (5/54) 3 2 - (Ong et al., 2012) 
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Table 1.4 RNF43 protein expressions in cancers. 
 
Cancers 
 
 
RNF43 protein 
expression 
 
 
References 
 
 
Hepatocellular carcinoma  
 
High (81%; 80/98) 
 
(Xing et al., 2013) 
Intraductal  papillary mucinous 
neoplasms 
High (70%; 124/176) (Sakamoto et al., 2015) 
Glioma High (61%; 141/229)  (Xi et al., 2015) 
Gastric carcinoma Low (57%; 44/77)  (Niu et al., 2015) 
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1.3 Thesis objectives 
 The aim of this thesis focused on RNF43 expression and its role in CCA.  
 1.  To investigate the RNF43 protein expression in 50 CCA tissues. 
 2. To investigate the RNF43 mRNA expression level in 28 frozen CCA tumors 
including the adjacent nontumorous tissue of the same patients. 
 3.  To investigate the association of RNF43 expression (mRNA or protein 
levels) and RNF43 somatic mutation status, clinicopathological features and survival 
of patients. 
 4.  To investigate the biological functions of RNF43 in CCA cell lines. 
1 
CHAPTER II 
MATERIALS AND METHODS 
 
2.1 Materials 
 2.1.1 Specimens 
 2.1.1.1 Tumor tissues and clinical data  
 Fifty paraffin-embedded blocks and 28 of 50 frozen tissues from CCA 
patients were obtained from the specimen bank of Liver Fluke and 
Cholangiocarcinoma Research Center, Faculty of Medicine, Khon Kaen University, 
Thailand.  
Written informed consent was obtained from each subject.  The Khon Kaen 
University Ethics Committee for Human Research and the Ethics Committee for 
Human Research (HE521209), Suranaree University of Technology, approved the 
protocol for sample collection (EC-57-25).  The clinicopathological features of the 
included cases are listed in Table 3.1.  The RNF43 mutation status was obtained from 
our previous study (Ong et al., 2012).  None of the patients received radiotherapy or 
chemotherapy before the surgery.  The survival of each CCA patient was recorded 
from the date of surgery until the patient died of the disease or to October 27, 2014.  
The follow-up time was at least 4 years, with median of 10 months and range of 1 to 
83 months. 
In case of paraffin embedded tissues were used for immunohistochemistry 
study and frozen tissues were used for performing RNA extraction and checking the 
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expression level. 
 2.1.1.2 Human cholangiocarcinoma cell lines  
   Human CCA cell lines including KKU-055, KKU-100, KKU-213 and 
KKU-214) were established from CCA patients at Srinagarind Hospital, Khon Kaen 
University, by Professor Banchob Sripa.  Certificates of analysis were obtained from 
the Japanese Collection of Research Bioresources Cell Bank, Osaka, Japan.  Four 
CCA cell lines were cultured in Ham’s F12 nutrient mixture medium with 10% (v/v) 
fetal bovine serum (FBS) (Gibco, New York, USA), 40 µg/mL of gentamicin, and 
0.25 µg/mL of amphotericin B (Gibco).  The cells were incubated at 37°C in a 
humidified atmosphere containing 5% CO2.  Cells with 70-80 % confluence were 
trypsinized with 0.25% trypsin-EDTA (Gibco) and subcultured in the same media.  
Some aliquots of cells were transferred to freezing medium containing 10% (v/v) 
DMSO and 50% (v/v) FBS and stored in a liquid nitrogen tank for later use.  CCA 
cell lines were used for gene expression and functional studies of RNF43. 
 
 
 2.1.2 Chemicals and antibodies  
  All chemicals and antibodies used in this study were presented in 
Table 2.1 
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Table 2.1 List of chemicals and antibodies. 
 
Chemicals  Company 
Plasmid Maxi kit  Geneaid Biotech (New Taipei, 
Taiwan) 
Liquid DAB+substrate chromogen system Dako (California, USA) 
Nitrocellulose membrane Bio-Rad (California, USA) 
Developer, replenisher and  
half-speed blue x-ray film 
Kodak (New York, USA) 
SYBR safe DNA gel stain and  
complementary DNA synthesis kit 
Invitrogen (California, USA) 
Prestained protein ladder GeneDirex (Keelung, Taiwan) 
Skimmed milk, Tryptone, yeast extract 
powder and agar powder  
Himedia Laboratories (Mumbai, 
India) 
Bovine serum albumin (BSA) ,  Sodium 
dodecyl sulphate (SDS) and 2-β-
mercaptoethanol   
Sigma-Aldrich (Missouri, USA) 
Phenylmethyl sulfonyl fluoride (PMSF)     
and Triton X-100 
USB Corporation (Ohio, USA) 
Dimethyl sulfozide (DMSO) Bio Basic Inc (Ontario, Canada) 
Tween-20  Scharlau chemie SA (Barcelona, 
Spain) 
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Table 2.1 List of chemicals and antibodies (Continued).  
 
 
 
 
 
 
 
 
 
 
 
Antibodies Company 
Rabbit polyclonal RNF43 antibody Sigma-Aldrich  
Rabbit polyclonal Phospho-β-catenin 
(Ser33/37/Thr41) antibody  
Cell Signaling Technology 
(Massachusetts, USA) 
Rabbit polyclonal β-Catenin, Frizzled,  and 
Cyclin D1 antibody 
Santa Cruz (Texas, USA) 
Mouse monoclonal β-Actin and Histone H1 
antibody 
Santa Cruz  
HRP labelled polymer anti rabbit and     
HRP labelled rabbit anti mouse IgG   
Dako 
HRP labelled goat anti rabbit IgG GenScript (New Jersey, USA) 
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 2.1.3 Oligonucleotide primers 
  The primer sequences used for RNF43 and β-actin expression were 
designed in-house by Primer-BLAST software 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/).  All primers were purchased from 
First BASE Laboratories Sdn Bhd (Selangor, Malaysia) (Table 2.2). 
 
Table 2.2 List of primer sequences.  
Primers 
Forward primer sequence 
(5’ 3’) 
 
Reverse primer sequence 
(5’ 3’) 
 
Product size 
(bp) 
β-actin 
GAT CAG CAA GCA 
GGA GTA TGA CG 
AAG GGT GTA ACG 
CAA CTA AGT CAT AG 
92 
RNF43 
TCT GTC TGG AGG 
AGT TCT CT 
CTC CCT CTG TGA 
TGT TGA AC 
138 
  
 2.1.4 Construction of RNF43-DDK-Myc expression vector and plasmid 
preparation 
   RNF43/pCMV6/neomycin-DDK-Myc construct and PCMV6-entry 
vector were purchased from Origene (Maryland, USA) (Figure 2.1).  Escherichea coli 
(E. coli) strain DH5α were purchased from Qiagen (Manchester, UK) and used for 
plasmid amplification.  RNF43/pCMV6/neomycin-DDK-Myc construct and PCMV6-
entry vector were transformed into E. coli strain DH5α and let the cells grown in 
Luria broth (LB, 10 g/L tryptone, 5 g/L yeast extract, 5 g/L sodium chloride) agar 
plate containing 25 μg/mL kanamycin for 16 h.  A single colony was picked into 500 
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µL of LB media containing kanamycin incubated at 37°C for 6 h with shaking at 200 
rpm.  Then, 0.5 mL of starter cultures were inoculated into 200 mL of LB containing 
kanamycin in a flask and incubated at 37°C with shaking until the OD600 reached 0.5-
0.6.  The bacterial cultures were cooled at 4°C, and then were purified using Plasmid 
Maxi kit (Geneaid Biotech).  In brief, bacterial cultures were harvested by 
centrifugation at 3,000 xg for 15 min to form a cell pellet, followed by resuspending 
the cell pellet with buffer.  Cells were lysed and neutralized, then transferred to the 
equilibrated Plasmid Maxi column and allowed column to empty by gravity flow.  
Then, the DNA binding columns were washed and eluted with a high salt buffer, 
followed by precipitation step of pure plasmid DNA.   Finally, double digestion was 
performed in RNF43/pCMV6 construct and PCMV6-entry vector using EcoRI and 
XhoI restriction enzymes to verify the purified plasmid. 
  
 
 
Figure 2.1 Mapping of pCMV6-entry (left) and RNF43 constructed (right) vector. 
 
 
31 
 
  
 2.1.5 Instrumentation 
  The instruments were used in this experiment, including of a shaking 
incubator (MRC ltd, Holon, Israel), a Thermomixer comfort and centrifuge 5415R 
(Eppendorf AG, Hamburg, Germany).  High-speed microcentrifuge CF16RXII 
(Hitachi, Tokyo, Japan), a microcentrifuge Denville 26OD (Denville Scientific, New 
Jersey, USA), a PCR 9700 thermocycler (PE Applied Biosystems, California, USA).  
CX21 light microscope and CKX41 inverted microscope (Olympus, New York, 
USA).  Biosafety laminar flow class II (Esco Lifesciences, Thailand), Forma series II 
water jacket CO2 incubator and Forma -80°C ULT freezer (Thermo Fisher Scientific, 
Massachusetts, USA).  Myrun DNA electrophoresis system (Cosmo Bio, Tokyo, 
Japan), A vertical mini protein gel electrophoresis system and The mini Trans-blot 
cell (Bio-Rad). 
 
2.2 Methodology 
 2.2.1 Determination of RNF43 protein and mRNA expression 
 2.2.1.1 Immunohistochemical analysis 
  Specimens were fixed in 10% neutral formalin buffer, embedded in 
paraffin, and cut into 5-μm-thick sections.  Immunohistochemical staining was 
performed using an immunoperoxidase method, with rabbit anti-human RNF43 
polyclonal antibody (Sigma-Aldrich;HPA008079).  In brief, each section was 
deparafinized and rehydrated by submerging in xylene and ethanol (respectively) with 
decreasing concentration.  The antigens were unmarked by heating each section (in 
0.1 mol/L citrate buffer, pH 6.0) in a microwave oven.  After inactivating the 
endogenous peroxidase (0.5% H2O2 in methanol, 30 min, room temperature) and 
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blocking nonspecific binding (20% normal horse serum 30 min, room temperature), 
sections were incubated with primary rabbit anti-human RNF43 polyclonal antibody 
(dilution 1:100) at room temperature for overnight, then incubated with HRP labelled 
polymer anti rabbit (Dako), according to the manufacturer’s instructions.  The section 
was visualized with 3,3′ -diaminobenzidine-tetrahydrochloride, Liquid DAB+ (Dako), 
and counterstainedwith hematoxylin.  
 Staining specificity was evaluated for all the staining batches, using a negative 
control staining condition (i.e., no primary antibody) and CCA tissue sections from 
the 2 CCA patients (codes W039 and T157 that showed positive staining in tumor 
cells, normal bile ducts, and hepatocytes).  Because there were no differences in 
staining intensity for each positive staining sample, the immunohistochemical results 
were evaluated as a frequency of RNF43-positive cells at the tumor area—classified 
into 4 scoring categories (0, negative; 1+, 1% - 10%; 2+, 11% - 50%; and 3+, >50%).  
Two researchers without any knowledge of the prognosis or clinicopathological 
variables evaluated the specimens.  In the statistical analysis, the scores 0 and 1+ were 
categorized as ―low expression‖; and the scores 2+ and 3+, as ―high expression.‖ 
 2.2.1.2 RNA Extraction  
  Total RNA was extracted from tumor tissues and adjacent 
nontumorous tissues of the same patient using the TRIzol reagent (Invitrogen).  In 
brief, frozen tissues were ground in liquid nitrogen with a mortar and pestle.  Tissues 
were then transferred into a 1.5 ml microtube containing of 1 ml TRIzol reagent and 
200 µl of chloroform then subsequently centrifuged at 12,000 xg for 15 min.  The 
aqueous phase (upper) with 500 µl was transferred and precipitated with 500 µl of 
isopropanol for 10 min.  RNA pellet was collected by centrifugation at 12,000 xg for 
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15 min and washed with 75% ethanol and left air dried.  The obtained RNA was 
finally resuspended in 20-40 µl double sterile distilled water.  The purity and 
concentration of the extracted RNA were checked by Nano Drop (NanoDrop 
Technologies, Delaware, USA) at the wavelength of 260 and 280 nm.  RNA integrity 
was checked by visualizing rRNA bands (28S and 18S) by agarose gel 
electrophoresis. 
 2.2.1.3 The complementary DNA (cDNA) synthesis 
  RNA was converted to cDNA by reverse transcription using 
Superscript VILO cDNA synthesis kit (Invitrogen) which contained random hexamer 
primers.  All reactions were set up on ice to avoid premature cDNA synthesis and to 
minimize the risk of RNA degradation.  Reverse transcription reaction was performed 
in a 20 µl containing 2 µg of template RNA, 5x buffer and 10x enzyme mix.  Total 
reaction was incubated for 60 min at 42°C.  The cDNA was diluted with sterile 
distilled water to make final concentration of cDNA at 10 ng/ µl for subsequent 
analysis or kept at -20°C. 
 2.2.1.4 Quantitative real-time polymerase chain reaction analysis 
  Expression levels of RNF43 gene were determined by SYBR-Green–
based real-time polymerase chain reaction (PCR) in Light Cycler 480 II machine 
(Roche Applied Science, Indiana, USA).  The PCR condition is summarized in Table 
2.3.  β-Actin served as the internal control for adjusting the amount of starter cDNA.  
Melting curve analysis was observed the presences of primer dimer formation and 
non-specific PCR product (Figure 2.2).  The relative expression of RNF43 gene was 
calculated using the 2
-ΔCT
 equation for each tumor tissue or adjacent nontumorous 
tissue.  The RNF43 messenger RNA (mRNA) expression of tumor tissues     
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compared to the adjacent nontumorous tissues of the same patients was 1.5-fold 
different. 
 
Table 2.3 The thermal cycling profiles of qPCR in Roche Lightcycler 480 
instrument. 
Reagent and condition RNF43 or β-actin 
Reaction volume                    20 µl 
2X SYBR green master mix  10 µl 
10 µM Forward and Reverse primer                              1 µl 
Template cDNA    (10 ng/ µl) 
Sterile distilled water  
5 µl 
4 µl 
 
PCR cycle 
 
 
 
Melting curve analysis 
 
      1 cycle   at  95°C 300 sec 
      40 cycle at  95°C 10 sec 
                          58°C 10 sec 
                          72°C 10 sec 
       1 cycle   at  95°C 5 sec 
                           65°C 60 sec 
PCR efficiency 2 
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Figure 2.2 Melting peaks of β-actin and RNF43 by melting curve analysis 
originated from an experiment on a Roche Lightcycler 480 instrument.  The RNF43 
amplicon has a melting temperature around 85°C, and (β-actin) internal control has a 
melting temperature around 84°C. 
 
 2.2.2 Investigating the biological role of RNF43 in CCA cell lines 
 2.2.2.1 Cell culture and transfections 
  CCA cell lines (KKU-055, KKU-213, KKU-214 and KKU-100) were 
cultured in Ham’s F12 nutrient mixture medium (Gibco) supplemented with 10% 
FBS, 40 µg/mL gentamicin, and 0.25 µg/mL amphotericin B (Gibco) in a humidified 
atmosphere of 5% CO2, at 37°C.  To generate CCA cell lines with transient RNF43 
expression, CCA cell lines were transfected with 2.5 μg of RNF43/pCMV6 construct 
or pCMV6 empty vector using Lipofectamine® 3000 (Invitrogen)  according to the 
manufacturer’s protocol.  After 48 h, CCA cell lines were harvested, measured 
RNF43 mRNA or proteins expression and used in subsequent experiments. 
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 2.2.2.2 Cell proliferation assay 
  Transfected cells were seeded (1-3 x 10
3
cells/well) in a 96-well plate 
in the presence and absent of Wnt3a at 5 nM and were incubated for 24 and 48 h.  The 
effects of RNF43 overexpression on CCA cell proliferation upon Wnt stimulation 
were measured using the colorimetric cell viability (MTS) assay using CellTiter 96 
Aqueous One Solution Reagent (Promega, Wisconsin, USA).  In vitro reduction of a 
tetrazolium compound 3-(4,5-dimethylthiazol-2-yl)-5-(3-carb oxymethoxyphenyl)-2-
(4-sulfophenil)-2H-tetrazolium (MTS) by metabolically active cells yielded a colored 
formazan that was released into the culture medium.  In brief, 20 µl/well MTS reagent 
was added into each well and then incubated for 2 h at 37°C in a humidified, 5% CO2 
atmosphere.  Color development in this assay was measured at 490 nm using a 
microplate spectrophotometer (Bio-Rad). 
 2.2.2.3 Transwell migration assay 
  Transfected cells (4 x 10
4
 CCA) suspending in 200 µl serum-free 
Ham’s F12 were seeded into the upper chambers of a transwell apparatus with a 8-m 
pore size of polycarbonate membrane (Corning Inc., New York, USA).  Then 600 µl 
of Ham’s F12 containing 10% FBS was added into the lower chambers as a 
chemoattractant.  After incubation for 15 h (KKU-213) or 22 h (KKU-214), cells on 
the upper membrane surface were wiped off, and the cells that migrated across the 
pore of polycarbonate membrane were fixed with 100% methanol and stained with 
0.5% crystal violet.  The number of migrating cells was then counted (6 - 9 low power 
fields with 4x magnifications for each membrane) by ImageJ software (National 
Institutes of Health (NIH) Image).  The percentage of migration was obtained from 
the following equation. 
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% Migration = 
                                 
                                    
   X 100 % 
 
 2.2.2.4 Stimulation of recombinant human Wnt3a  
  Determination of intracellular proteins in RNF43 overexpressing cells 
and control cells, Wnt3a at 5 nM (R&D Systems, Minnesota, USA) or bovine serum 
albumin (BSA) was used to activate Wnt signaling pathway for 24 h.  The culture 
medium was then removed and the cells were washed with phosphate-buffered saline 
(PBS).  Then the cells were lysed for protein collection and western blot analysis. 
 2.2.2.5 Whole cell lysate preparation 
  Cells were washed with PBS and lysed with lysis buffer pH 7.5 (20 
mM Tris-base, 150 mM NaCl, 1% Triton X-100, and protease inhibitors) and 
incubated on ice for 30 min.  Cell lysates were clarified by centrifugation at 16,000 xg 
for 20 min at 4°C.  Protein concentration was determined with Novagen
®
 BCA 
protein assay kit (EMD Chemicals, Darmstadt, Germany). 
 2.2.2.6 Nuclear extraction 
  Cells were collected and washed with PBS.  Cells were lysed in 
hypotonic buffer (10 mM HEPES [pH 7.9], 10 mM KCl, 0.1 mM EDTA, 1 mM 
dithiothreitol [DTT], 0.25% NP-40, and protease inhibitors), and incubated on ice for 
10 min.  After centrifuging at 6000 rpm for 4 min at 4°C, the nuclear pellet was lysed 
in nuclear lysis buffer (20 mM HEPES [pH 7.9], 0.4 M NaCl, 1 mM EDTA, 1 mM  
DTT, and protease inhibitors), and incubated on ice for 15 min.  Nuclear extracts were 
obtained by centrifugation at 14,000 rpm for 5 min. 
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 2.2.2.7 Western blot analysis 
  Protein samples were mixed with 4x non-reducing Laemmli sample 
buffer to get the final concentration of 1x buffer and were boiled for 5 min by heat 
block (Labnet, New Jersey, USA).  Then, protein samples were resolved by SDS-
polyacrylamide gel electrophoresis on a 10% separating gel, transferred onto 
nitrocellulose membranes by wet/tank electroblotting systems, and incubated with 
primary antibodies overnight at 4°C after blocking with 5% low-fat milk.  Secondary 
antibodies goat anti-rabbit IgG (GenScript) or rabbit anti-mouse IgG (Dako) 
conjugated with horseradish peroxidase were used for signal visualization with 
SuperSignal
®
 West Pico Chemiluminescent Substrate kit (Thermo Fisher Scientific).  
Intensities of the signals examined were quantified using ImageJ software (NIH) and 
normalized by the internal loading control.  Antibodies used in this study were RNF43 
(Sigma-Aldrich), Phosphorelated β-catenin (Cell Signaling), β-catenin, Frizzled, 
Cyclin D1, Histone H1, and β-actin (Santa Cruz). 
 2.2.2.8 Statistical analysis 
  The statistical analysis of the CCA data was carried out using SPSS 
statistical software version 16.0.1 (SPSS, Illinois, USA).   RNF43 mRNA expression 
from tumor tissues were compared with those of adjacent nontumorous tissues those 
of the control group using the independent Student t test or the Mann-Whitney U test.  
Cross-tabulations and chi-squared test were used to analyze the associations between 
RNF43 mRNA or protein expression and the clinicopathological features of CCA 
patients, and RNF43 mutations.  The Kaplan-Meier survival analysis was used to 
estimate overall survival and comparison between groups done using the log-rank test.  
The statistical significance was accepted if P value ≤ 0.05. 
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 The data obtained from functional studies on RNF43 including cell 
proliferation and migration assay were expressed as the mean + SD and were 
compared using Student’s t-tests, with a P value of ≤ 0.05 taken as statistically 
significant.
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CHAPTER III 
RESULTS 
 
3.1 RNF43 protein expression in cholangiocarcinoma tissues 
  Immunohistochemical staining of 50 CCA tissues showed that, in 
nontumorous area, RNF43 protein was expressed in the nuclei of hepatocytes and 
normal bile duct epithelium (Figure 3.1).  By comparison, RNF43 protein expression 
varied in the tumor tissues (CCA cells), high expression was identified in 36% (n = 
18) with specific diffuse nuclear staining for the RNF43, whereas the remaining 64% 
(n = 32) with focal or negative staining were evaluated as a low or absent expression. 
 We further quantitatively analyzed the correlation between RNF43 protein 
expression in CCA cells and the clinicopathological features, using a univariate 
analysis. There was no statistically significant association between RNF43 protein 
expression and age, sex, histologic types, tumor stages, vascular or lymphatic 
invasion, or somatic mutation (Table 3.1).  However, the absent RNF43 protein 
expression was examined in 5 CCA patients with RNF43 somatic mutations 
(including 3 missense and 2 nonsense mutations, Supplementary Table 1). 
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Figure 3.1  Immunohistologic analysis indicates high RNF43 protein expression in 
nontumorous area: in the nuclei of hepatocytes (A), normal bile duct epithelium (B), 
and tumor area (C) CCA cells with high expression and absence of RNF43 proteins 
(D). Arrows indicate hepatocytes at junction area. Original magnification, ×100. 
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Table 3.1 Association between RNF43 protein expression and clinicopathological 
features (n = 50). 
 
Variables 
RNF43 protein expression 
 
P* 
 
Low (n = 32) High (n = 18) 
 
Age (y) 
      < 56 14 6 0.470
   ≥ 56 18 12 
 Sex 
      Male  4 6 0.077
   Female 28 12 
 Histologic type 
      Papillary type 12 9 0.390
   Nonpapillary type 20 9 
 Stage 
      I - III 16 9 0.942
   IV 16 9 
 Lymphatic invasion 
      Present 24 12 0.529
   Absent 8 6 
 Vascular invasion 
      Present 23 12 0.700
   Absent 9 6 
 RNF43 somatic mutation 
      Mutant 5 0 0.077
   Wild type 27 18   
* P ≤ 0.05, considered statistically significant. 
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3.2 Down-regulation of RNF43 protein expression associated with 
poor patient survival 
 The Kaplan-Meier analysis provided an estimate of the overall survival 
stratified by RNF43 protein expression (absent or low versus high) (Figure 3.2).  One 
patient died perioperatively (survived < 30 days), so was excluded from the analysis.  
Patients with absent or low expression of RNF43 had significantly shorter overall 
survival than patients with high RNF43 expression (median overall survival, 237 ± 31 
versus 475 ± 97 days; P = 0.016, log-rank test).  Several clinicopathological 
parameters have been shown to correlate with the prognosis of CCA patients.  We, 
thus, assessed whether RNF43 protein expression was a confounding factor—
underlying the clinical conditions—by performing univariate and multivariate Cox 
proportional hazard regression analysis.  The results showed that age, sex, and RNF43 
protein expression were significant prognostic factors associated with overall survival 
(Table 3.2).  The multivariate Cox regression model for survival, which controlled for 
age, sex, histology types, tumor stages, lymphatic invasion, vascular invasion, and 
RNF43 protein expression of the patients, indicated that only RNF43 protein 
expression (between low and high) was potentially an independent predictor of CCA 
survival (hazard ratio, 1.961 [95% confidence interval, 0.981-3.920]; P = 0.057) 
(Table 3.2). 
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Figure 3.2 Cumulative overall survival determined using Kaplan-Meier analysis 
for CCA patients with high protein expression of RNF43: they had significantly better 
survival than those with low protein expression of RNF43. Black circles indicate 
censor cases. 
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Table 3.2 Univariate and multivariate analyses of factors associated with survival.   
 
 
Variables 
Univariate analysis 
a
 
 
Multivariate analysis 
a
 
 
Hazard ratio  (95% CI) P 
 
Hazard ratio (95% CI) P
 b
 
Age:  > 56 vs < 56 years 2.143 (0.986 – 4.656) 0.049 
 
1.746 (0.754 – 4.042) 0.193 
Sex:  male vs female 1.210 (0.666 – 2.198) 0.053 
 
1.206 (0.640 – 2.270) 0.562 
Histologic type: papillary  vs nonpapillary 1.739 (0.945 – 3.198) 0.071 
 
1.336 (0.656 – 2.720) 0.424 
Tumor stage: VI vs I-III 0.951 (0.529 – 1.709) 0.865 
 
0.803 (0.396 – 1.628) 0.542 
Lymphatic invasion:  present vs absent 1.067 (0.553 – 2.061) 0.846 
 
0.756 (0.339 – 1.688) 0.495 
Vascular invasion:  present vs absent 1.748 (0.920 – 3.320) 0.083 
 
1.822 (0.881 – 3.767) 0.106 
RNF43 protein expression:  low vs high 2.142 (1.137 – 4.036) 0.016   1.961 (0.981 – 3.920) 0.057 
      Abbreviation: CI, confidence interval. 
 
a
 Cox proportional hazards regression. 
 
b
 Partial likelihood ratio test. 
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3.3 Genetic alterations of RNF43 in cholangiocarcinoma 
 To address the association between genetic alteration status (mRNA 
expression level, and mutations) and RNF43 protein expression, we obtained 28 
frozen CCA tumors from the total 50 CCA cases including the adjacent nontumorous 
tissue of the same patient and determined the RNF43 mRNA expression levels using 
the quantitative real-time PCR (qPCR) assay.  The median RNF43 mRNA expression 
of 28 CCA tumors was 6.88 (range 2.11-35.62) which was lower than those of 28 
adjacent nontumorous tissue with a median of 10.20 (1.30-45.88).  However, there 
was no statistically significant difference between these two tissues.  We then further 
analyzed the difference of RNF43 mRNA expression between CCA tumor and 
adjacent nontumorous tissues of the same patient to minimize the background which 
due to use of bulky tissues.  Down-regulation of RNF43 mRNA expression in CCA 
tissues was identified in 43% (n = 12), whereas remaining CCA tissues had up-
regulated (25%; n = 7) or no change (32%; n = 9) in the RNF43 mRNA expression 
(Figure 3.3).  The relationship between the mRNA expression and the protein 
expression or clinicopathological features was observed using a univariate analysis.  
There was no statistically significant association between RNF43 mRNA expression 
and protein expression or the clinicopathological features tested (Table 3.3).  In 
addition, Kaplan-Meier analysis demonstrated that CCA patients with down-
regulation of RNF43 mRNA expression were had significantly shorter survival 
compared with those of the patients with up-regulation of RNF43 mRNA expression 
(Figure 3.4; P = 0.037). 
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Figure 3.3 RNF43 mRNA expression level down-regulated in 
cholangiocarcinoma. The expression level of RNF43 was analyzed by qPCR and 
normalized using β-actin as reference gene. RNF43 expression of the 28 CCA cases 
was grouped into 3 categories based on the fold change between tumor tissues and 
adjacent nontumorous tissues of the same patient.   
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Table 3.3 Association between RNF43 mRNA expression and 
clinicopathological features (n = 28).  
 
 
Variables 
RNF43 mRNA expression 
 
P* 
 
Down-regulated Up-regulated No change 
 
 
(n = 12) (n = 7) (n = 9) 
 
Age (y) 
       < 56 2 2 1 0.657 
   ≥ 56 10 5 8 
 Sex 
       Male  9 3 3 0.134 
   Female 3 4 6 
 Histologic type 
       Papillary type 2 3 3 0.442 
   Nonpapillary type 10 4 6 
 Stage 
       I - III 4 4 4 0.595 
   IV 8 3 5 
 Lymphatic invasion 
       Present 6 2 2 0.380 
   Absent 6 5 7 
 Vascular invasion 
       Present 3 4 3 0.364 
   Absent 9 3 6 
 RNF43 protein expression 
      Absent or low 8 4 6 0.792 
   High 3 3 3   
* P ≤ 0.05, considered statistically significant. 
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Figure 3.4 Cumulative overall survivals between CCA patients with RNF43 
mRNA up-regulation and down-regulation determined using Kaplan-Meier analysis. 
CCA patients with up-regulation: they had significantly better survival than those 
with down-regulation of RNF43 mRNA. Black circles indicate censor cases.   
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3.4 The functional analysis of RNF43 in CCA cell lines 
 3.4.1 Endogenous RNF43 mRNA expression in CCA cell lines 
  We investigate the role of RNF43 in vitro.  Firstly, the endogenous 
RNF43 mRNA and protein expression were determined in CCA cell lines including 
KKU-055, KKU-100, KKU-213 and KKU-214 using qPCR and Western blot 
analysis.  High expression of RNF43 mRNA was demonstrated in both KKU-214 and 
KKU-213 while KKU-055 and KKU-100 had a relatively low endogenous mRNA 
level of RNF43 (Figure 3.5).  However, the endogenous RNF43 protein was not 
detectable in all CCA cell lines (Figure 3.6).  This is perhaps due to low levels of 
endogenous RNF43 mRNA in all CCA cell lines which have been detected at late 
stage of PCR cycle (PCR cycle range at 29-35).  In addition, down-regulation of 
RNF43 may occur in the particular patient who donated the CCA tissues for 
establishing CCA cell lines.   
 To study the biological role of RNF43 in these CCA cell lines via 
overexpression model, CCA cell lines were transfected with RNF43/pCMV6 
construct or pCMV6 empty vector using lipofectamine 3000 and incubated for 48 h. 
Western blot analysis demonstrated that the exogenous RNF43 protein was expressed 
in KKU-055, KKU-213, and KKU-214 with RNF43/pCMV6 construct except KKU-
100 (Figure 3.7) when compared to those cells with control vector.  The result of 
protein expression is consistent with the RNF43 mRNA expression for all three CCA 
cell lines (Figure 3.8).    
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Figure 3.5 The endogenous RNF43 mRNA expression in four human CCA cell 
lines. The relative expression level of RNF43 was analyzed by qPCR and normalized 
using β-actin as reference gene.  Data are presented as mean + SD of two dependent
experiments. 
 
Figure 3.6 The endogenous RNF43 protein expression in four human CCA cell 
lines; KKU-214, KKU-213, KKU-055, and KKU-100.  The whole cell lysates were 
subjected to Western blotting.  293T cell (originally derived from human embryonic 
kidney cell containing the SV40 T-antigen) expressing RNF43 was used as a positive 
control.  kD; kilodalton 
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Figure 3.7 The exogenous RNF43 protein expression in four human CCA cell 
lines KKU-055, KKU-213, KKU-214, and KKU-100.  Whole cell lysates was used to 
determine the protein level of RNF43 in four human CCA cell lines that transfected 
with RNF43/pCMV6 construct or pCMV6 emtry vector for 48 h.  293T cell 
expressing RNF43 was used as a positive control.  The β-actin level indicates equal 
amounts of total protein.  kD; kilodalton 
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Figure 3.8 The exogenous RNF43  mRNA expression in three human CCA cell lines 
KKU-055, KKU-213, and KKU-214.  The total RNA was extracted after transfection 
for 48 h and the RNF43 mRNA expression was performed using qPCR analysis.  β-
actin was used as reference gene.  The fold change of RNF43 mRNA expression was 
calculated by 2
-Ct
.  Data are presented as mean + SD of two dependent experiments.   
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 3.4.2 The restoration of RNF43 gene expression reduces the proliferation 
rate of CCA cell line upon Wnt3a stimulation. 
 We investigated whether the effect restoration of RNF43 expression in 
CCA cell lines alter the rate of cell proliferation and migration upon Wnt stimulation.  
Firstly, KKU-055 was selected to determine the role of RNF43 in vitro because it had 
a relatively low endogenous level of RNF43 among all CCA cell lines and showed 
high effeciency of transfection with low cytotoxicity.  The results showed that 
exogenous RNF43 expression was expressed in KKU-055 (Figure 3.7).  However, 
there was no changed on cell proliferation and migration in KKU-055 expressing 
RNF43 as compared to control cells (Figure 3.9 and 3.10).  To study the potential 
function of RNF43 in CCA ,we changed to use KKU-213 and KKU-214 instead as an 
in vitro model.  Although, KKU-213 and KKU-214 showed high endogeous mRNA 
level of RNF43, however,  the protein level was not detectable.  Thus, these two CCA 
cell lines were forced to express RNF43 using RNF43/pCMV6 construct (Figure 3.7).  
We examined the effect of RNF43 expression on the growth of the two CCA cell 
lines.  The results showed that RNF43 expression reduced proliferation rate of both 
cell lines after 24 and 48 h of incubation.   Moreover, stimulation with Wnt3a at 5 nM 
significantly decreased the growth of KKU-213 (P < 0.001) and KKU-214 (P < 0.05) 
expressing RNF43 in a time-dependent manner (after 24 and 48 h of incubation) 
where Wnt3a stimulation had no influence to rate of cell proliferation in CCA cell 
lines (Figure 3.11 and Supplement Figure 1 and 2).  A Transwell migration assay was 
subsequently carried out to determine whether RNF43 expression affects the 
migration of CCA.  The number of migrating cells in KKU-213 or KKU-214 
expressing RNF43 was found to be relatively lower than those cell with control vector 
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(Figure 3.12).   However, there was no statistically significant observed between 
RNF43 overexpression and cell migration. 
 
 
 
 
 
Figure 3.9 Effects of RNF43 on cell proliferation in KKU-055 cells.  The MTS 
assay was performed to measure the cell viability in KKU-055 expressing RNF43 or 
pCMV6 empty vector at 24 and 48 h.  Percentage of cell proliferation was normalized 
to absorbance of KKU-055 transfected with pCMV6 empty vector at 0 h.  Data 
represent the mean ± SD of two independent experiments. 
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Figure 3.10 Effects of RNF43 on cell migration in KKU-055 cell.  KKU-055 
expressing RNF43 or pCMV6 empty vector were loaded into the upper chamber of a 
well in a Transwell plate and incubated for 22 h.  Number of migrating cells were 
counted (Left panels) from six random microscopic field and representative image of 
migrating cell in the chamber are shown for each condition (Right panels).  Data 
represent the mean ± SD of three independent experiments and the percentage of cell 
migration was normalized to that of KKU-055 transfected with pCMV6 empty vector 
which was assumed to be 100%. 
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Figure 3.11 Overexpression of RNF43 reduces the growth of CCA cell lines.  The 
MTS assay was performed to measure the cell viability in KKU-213 (A) and KKU-
214 (B) expressing RNF43 or pCMV6 empty vector at 24 and 48 h.  Percentage of 
cell proliferation was normalized to absorbance of KKU-213 or KKU-214 transfected 
with pCMV6 empty vector at 0 h.  Data represent the mean ± SD of two independent 
experiments.   *P < 0.05, **P < 0.001, t-test. 
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Figure 3.12 Overexpression of RNF43 does not alter the migration ability of CCA 
cell lines.  The two CCA cell lines (KKU-213 and KKU-214) expressing RNF43 or 
pCMV6 empty vector were loaded into the upper chamber of a well in a Transwell 
plate and incubated for 15 h (KKU-213) and 22 h (KKU-214).  Number of migrating 
cells were counted (Lower panels) from six random microscopic fields and 
representative images of migrating cell in the chamber are shown for each condition 
(Upper panels).  Data represent the mean ± SD of three independent experiments and 
the percentage of cell migration was normalized to that of KKU-213 or KKU-214 
transfected with pCMV6 empty vector which was assumed to be 100%. 
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 3.4.3 The change in RNF43 expression affects the activation of Wnt 
signaling 
  To study the molecular mechanism of RNF43-reduced the growth of 
CCA cell lines, Western blot analysis was performed to determine the change in 
expression level of RNF43 and Wnt signaling proteins.  Our data demonstrated that 
exogenous RNF43 protein was detected in the whole cell lysate from both KKU-213 
and KKU-214 cell lines expressing RNF43 in comparison with control vector.  
Subcellular fractionation demonstrated that exogenous RNF43 protein was 
prominently expressed in the nucleus fraction when compared to cytoplasmic fraction.  
Forced overexpression of RNF43 was able to suppressed the activaton of Wnt 
signaling in both CCA cell lines (KKU-213 and KKU-214), evidenced by reducing 
the level of frizzled protein, increased the phosphorylation of β-catenin 
(Ser33/37/Thr41) and decreased the protein level of cyclin D1.  Similar result was 
observed on KKU-213 and KKU-214 expressing RNF43 under Wnt3a stimulation 
(Figure 3.13).  Therefore, these results suggested that decreased the protein level of 
frizzled and cyclin D1, major downstream targets of Wnt signaling, induced by 
RNF43 might play a key role in negative regulation of proliferation in CCA. 
 
 
60 
 
  
  
Figure 3.13 Overexpression of RNF43 suppresses the activation of Wnt signaling 
pathway.   KKU-213 and KKU-214 were transiently transfected with RNF43/pCMV6 
construct or pCMV6 empty vector for 48 h. and then treated with 5 nM of Wnt3a for 
24 h.  The whole cell lysates were subjected to Western blotting and probed with an 
antibody specific to RNF43, frizzled, phosphorylated β-catenin, cyclin D1 and β-actin 
while the protein level of RNF43, β-catenin were also performed in nuclear protein 
fractions.  Histone H1 and β-actin were used as a loading control to indicate the equal 
amount of total protein from nucleus fractions and whole cell lysate, respectively.  
Intensity of the immunoreactive bands were measured by ImageJ software (NIH). 
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CHAPTER IV 
DISCUSSION AND CONCLUSION 
 
 RING finger ubiquitin-protein ligases (E3s) are the most abundant class of E3 
that mediate protein ubiquitination.  They regulate crucial cellular functions, such as 
the cell cycle, DNA repair, cell signaling and responses to hypoxia.  It has become 
evident that many RING finger E3s are implicated in malignancy.  Some are validated 
oncogenes (such as MDM2) or tumor suppressor genes (such as BRCA1 and von 
Hippel–Lindau tumor suppressor (VHL)) because of their role in regulating crucial 
cell functions (Lipkowitz and Weissman, 2011).  Ring finger protein 43 or RNF43 
belongs to the family of E3 finger ubiquitin-protein ligases.  It has been demonstrated 
that the loss-of-function mutation in RNF43 acts as either an oncogene or a tumor 
suppressor gene depending on the tumor type.  In CCA, RNF43 was thought to act as 
a tumor suppressor gene because CCA patients with inactive RNF43 mutations are 
associated with poorer survival (Ong et al., 2012).  In the present study, we 
determined the expression level of RNF43 in both mRNA and protein levels in CCA 
tissues and its role in CCA cell lines.  Most of the CCA tissues showed predominantly 
down-regulated RNF43 expression from both mRNA and protein levels using qPCR 
and immunohistochemistry technique, respectively. The expression results from 
mRNA and protein levels of RNF43, which showed the same trend, although no 
statistically significant expression of RNF43 mRNA was found in CCA tissues.  This 
is perhaps due to use of bulky CCA tissues, which were possibly contaminated with 
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both hepatocytes and stromal cells.  Down-regulation of RNF43 protein expression 
was significantly associated with less survival of CCA patients.  Univariate and 
multivariate analyses revealed that RNF43 protein expression was a potential 
independent prognostic factor of CCA.  Our findings are thus consistent with a study 
of glioma and gastric cancer, in which decreased expression of RNF43 was associated 
with a poor prognosis (Niu et al., 2015; Xi et al., 2015).  However, there was no 
statistically significant association between RNF43 protein expression and age, sex, 
histologic types, tumor stages, vascular or lymphatic invasion, or somatic mutation.  
According to RNF43 protein expression in the CCA tissues—especially the 5 CCA 
patients with 3 missense and 2 nonsense mutations, which showed absent RNF43 
protein expression in tumor cells—we, nevertheless, observed protein expression in 
the normal bile duct epithelium.  This result confirmed the prediction of our previous 
study (Ong et al., 2012) that the 3 missense mutations are functionally damaged.  
Since, we frequently noted the down-regulation of RNF43 rather than the detection of 
any RNF43 somatic mutations.  This result implies us that epigenetic alteration might 
account for the reduced expression in addition to a somatic mutation.  Wang et al. 
recently demonstrated that miR550a-5p directly targets the 3′UTR of RNF43, thereby 
regulating the protein expression of RNF43 (Wang et al., 2016).  Taken together, the 
results so far imply that down-regulation of RNF43 may play a role in 
cholangiocarcinogenesis. 
 RNF43 is proposed as a negative Wnt regulator by reducing frizzled receptor 
surface expression (Koo et al., 2012).  In the current study, we provided convincing 
evidence that RNF43 decreased cell proliferation in CCA via regulating frizzled 
receptors in Wnt signaling pathway.  Our data demonstrated that down-regulation of 
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RNF43 was observed in all CCA cell lines but KKU-055 had a relatively low 
endogenous expression of RNF43 among all CCA cell lines.   This is perhaps due to 
down-regulation of RNF43 may occur in the particular patient who donated the CCA 
tissues for establishing CCA cell lines.  RNF43 expression was restored in KKU-055, 
KKU-213 and KKU-214 by transfecting with RNF43/pCMV6 construct.   MTS 
demonstrated that restoration of RNF43 expression reduced proliferation rate of both 
KKU-213 and KKU-214.  However, there was no change on the growth of KKU-055 
expressing RNF43.   This result implies that the effect of RNF43 on cell growth is a 
cell-type specific.  Moreover, the significance of RNF43 on cell growth was evidently 
observed upon Wnt3a stimulation in particular of KKU-213 expressing RNF43 where 
stimulation of Wnt3a on parental CCA cells did not show the influence on the growth 
of CCA cell lines (Supplementary Figure 1 and 2).  This result agrees with the studies 
in pancreatic and gastric cancers in which RNF43 expression inhibits cell 
proliferation and lead to induces cell apoptosis (Niu et al., 2015) while  the 
overexpression of RNF43 in hepatocellular carcinoma  reveals oncogenic function by 
promoting cell proliferation and invasion (Xing et al., 2013).  In addition, the role of 
RNF43 on cell migration and invasion has also been observed for several cancers.  
Wang et al. demonstrated that the decreased protein expression of RNF43 is regulated 
by miR550a-5p which directly targets the 3′UTR of RNF43.  This process leads to 
increase cell migration in colorectal cancer (Wang et al., 2016).  In CCA, transwell 
migration assay indicates that RNF43 does not play a significant role in CCA cell 
migration.   Hence, it can be concluded that RNF43 has a role in CCA progression by 
reducing the growth of CCA cells.  
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RNF43 has been demonstrated to inactivate Wnt signals via 1) interacting with 
the Wnt receptors of the frizzled, and 2) sequestering TCF4 to the nuclear membrane 
(Jiang et al., 2013; Koo et al., 2012; Loregger et al., 2015).  Inactivation mutation of 
RNF43 has been identified in CCA patients with poor prognosis (Ong et al., 2012).  
Moreover, down-regulation of RNF43 mRNA or protein was associated with genetic 
alteration status including somatic mutation and polymorphism (Talabnin et al., 
2016).  However, functional study of RNF43 in vitro or in vivo had not been 
conducted in CCA.  Here, we show that forced overexpression of RNF43 was able to 
suppressed the activation of Wnt signaling in CCA cell lines (KKU-213 and KKU-
214), evidenced by reducing the level of frizzled protein, increased the 
phosphorylation of β-catenin (Ser33/37/Thr41) and decreased the protein level of 
cyclin D1.  Upon Wnt3a stimulation significantly reduced the protein level of cyclin 
D1 in particular of KKU-213 expressing RNF43.  This result is consistent with the 
finding from MTS assay that showed markedly reduction of cell growth in KKU-213 
expressing RNF43 with Wnt3a stimulation.  These results indicates that RNF43 
decreased cell growth by reducing the membrane level of frizzled in CCA cell line 
and then promotes the inactivation of Wnt signaling pathway by increasing β-catenin 
protein degradation.  Similar observation has been previously reported in pancreatic 
ductal adenocarcinoma (Jiang et al., 2013).  Since, the function of RNF43 is also 
proposed in nucleus by interacting with TCF4 in the nucleus and then tethers TCF4 to 
the nuclear membrane, thus silencing TCF4 transcriptional activity and inactivation of 
Wnt signaling (Loregger et al., 2015).  In CCA, RNF43 was mainly expressed in 
nuclei of tumor cells in CCA tissues and RNF43 overexpressing CCA cell lines.  
Thus, further investigation is required to clarify the role of nuclear RNF43 in CCA.  
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 In conclusion, this study confirms the frequent down-regulation of RNF43 in 
CCA samples based on qPCR and IHC studies.  CCA patient with reduced RNF43 
mRNA or protein expression was associated with poor prognosis.  RNF43 protein 
expression was identified as an independent prognosis factor of overall survival in 
CCA.  The suppressive role of RNF43 in regulating Wnt signaling was observed to 
control the growth of CCA cells.  Present study suggests that RNF43 in CCA has a 
tumor suppressive function and the identification of genetic alteration status of 
RNF43 may provide specific therapeutic strategies for patient treatment.  
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Supplementary Figure 1 Effect of Wnt3a stimulation on cell proliferation. KKU-
213 and KKU-214 cells were transiently transfected with pCMV6 empty vector. The 
MTS assay was performed to measure cell viability of KKU-213 (Left) and KKU-214 
(Right) after incubation for 24 and 48 h.  Percentage of cell proliferation was 
normalized to absorbance of KKU-213 or KKU-214 transfected with pCMV6 empty 
vector at 0 h.  Data represent the mean ± SD of two independent experiments. 
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Supplementary Figure 2 Effect of Wnt3a stimulation on cell migration. KKU-
213 and KKU-214 were transiently transfected with pCMV6 empty vector.  The 
transfected cells were loaded into the upper chamber of a well in a Transwell plate 
and incubated for 15 h (KKU-213, Left) and 22 h (KKU-214, Right).  Number of 
migrating cells were counted from six random microscopic field.  Data represent the 
mean ± SD of two independent experiments and the percentage of cell migratin was 
normalized to that of KKU-213 or KKU-214 transfected with pCMV6 empty vector 
which was assumed to be 100%. 
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Supplementary Table 1 RNF43 somatic mutations and RNF43 protein expression in 5 CCA. 
CCA Histological type Stage RNF43 mutation  Immunohistochemistry Result 
 
A074 
 
WD tubular adenocarcinoma 
 
IVA 
 
Missense (p.T204R) 
 
Negative   
(+ve on normal and Dilatation of BD) 
A159 Papillary carcinoma IIIB Nonsense (p.R113X) Negative 
(+ve on  normal and Dilatation of BD) 
R104 WD tubular adenocarcinoma III Missense (p.C119R) Negative 
U044 Papillary carcinoma IIIB Missense (p.N167I) Negative 
W012 WD tubular adenocarcinoma III Nonsense (p.Q723X) Negative   
(+ve on normal and Dilatation of BD) 
Abbreviation BD; Bile Duct 
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